title: Which is the most reliable diagnostic modality for detecting locally residual or recurrent laryngeal squamous cell carcinoma after (chemo)radiotherapy?
authors.affiliation: Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital, Berne, Switzerland.
authors.forename: Peter
authors.initials: P
authors.lastname: Zbären
authors.forename: Remco
authors.initials: R
authors.lastname: de Bree
authors.forename: Robert P
authors.initials: RP
authors.lastname: Takes
authors.forename: Alessandra
authors.initials: A
authors.lastname: Rinaldo
authors.forename: Alfio
authors.initials: A
authors.lastname: Ferlito
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000628:therapy; D059248:Chemoradiotherapy; D038524:Diffusion Magnetic Resonance Imaging; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007822:Laryngeal Neoplasms / Q000175:diagnosis* / Q000628:therapy; D008279:Magnetic Resonance Imaging; D064847:Multimodal Imaging; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D018365:Neoplasm, Residual; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D014057:Tomography, X-Ray Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18